Coeptis Therapeutics Holdings, Inc.
COEP
$9.75
$0.272.85%
| 09/30/2024 | 06/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -55.54% | 28.17% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -24.27% | -3.23% | |||
| Operating Income | 24.27% | 3.23% | |||
| Income Before Tax | 39.75% | -1.13% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 39.75% | -1.13% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 39.75% | -1.13% | |||
| EBIT | 24.27% | 3.23% | |||
| EBITDA | 26.62% | 3.53% | |||
| EPS Basic | 43.13% | 4.32% | |||
| Normalized Basic EPS | 44.29% | 4.32% | |||
| EPS Diluted | 43.13% | 4.32% | |||
| Normalized Diluted EPS | 44.29% | 4.32% | |||
| Average Basic Shares Outstanding | 5.95% | 5.70% | |||
| Average Diluted Shares Outstanding | 5.95% | 5.70% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||
